KL and cancer: Since soluble Klotho can inhibit IGF-1, Wnt and transforming growth factor-β (TGF-β) signaling pathways in aging and in certain cancers [31], whether these pathways are involved in the Klotho-induced regulation of bone formation still needs to be investigated.